STERIS (STE) DIvidends Date & History

Key Takeaways

• STERIS plc (STE) offers a modest dividend yield of approximately 1.21%, with an annualized payout of $2.52 per share.
• The company has raised its dividend for 20 consecutive years, reflecting strong commitment to shareholders.
• A low payout ratio of 33.5% ensures ample earnings coverage, supporting ongoing sustainability.
• Free cash flow (FCF) of $870.7 million (TTM) comfortably covers dividends, with healthy cash payout ratios around 27%.
• Dividend growth averages about 10% annually over the past 3-5 years, positioning STE as a reliable growth contender.
• Upcoming ex-dividend date is June 8, 2026, with payment on June 26, 2026, at $0.63 per share.

Dividend Overview

STERIS plc (STE), a leader in infection prevention and medical device sterilization, maintains a quarterly dividend policy with a current yield of 1.21% based on a forward annual dividend of $2.52 per share. The most recent quarterly payout is $0.63 per share, payable on June 26, 2026, to shareholders of record by June 8, 2026. This modest yield reflects STE's profile as a dividend growth stock rather than a high-yield play. With consistent quarterly payments and a history of double-digit increases, the dividend appeals to investors seeking reliable income paired with capital appreciation in the healthcare sector. The policy balances reinvestment in growth areas like sterilization services and procedural equipment while rewarding shareholders.

Dividend History and Growth

STERIS has demonstrated impressive dividend discipline, increasing its payout for 20 consecutive years—the most recent being a raise to $0.63 per share, up about 10% annually in line with recent trends. Over the past 3 years, dividend growth averaged 9.7%, while 5-year growth reached approximately 9.3%. Historical data shows steady progression: from $0.47 in 2022 to the current $0.63 quarterly rate. No cuts have occurred in decades, underscoring a long-term strategy tied to recurring revenues from healthcare and life sciences segments. This consistency positions STE as a standout in medical devices, where growth often prioritizes reinvestment over aggressive payouts.

Dividend Sustainability and Payout Ratio

STE's dividend is highly sustainable, backed by a trailing payout ratio of 33.5%—well below 60%, leaving room for growth and resilience. Trailing EPS of $7.18 covers the $2.52 annual dividend over 2.8 times. Levered free cash flow (FCF) of $870.7 million (TTM) provides even stronger support, with cash payout ratios around 27%, indicating dividends consume less than a third of available cash after capital expenditures. Debt-to-equity stands at a manageable 28.65%, and interest coverage exceeds 17x, bolstering financial stability. Recent FCF growth, up 27% year-over-year to $787 million annually, further affirms capacity to maintain and potentially accelerate payouts amid steady earnings expansion.

Dividend Compared to Industry Peers

In the medical devices industry, STE's 1.21% yield is competitive and roughly in line with peers, surpassing many growth-oriented players while trailing higher-yield names. For context, SYK (Stryker) yields about 1.2%, and BDX (Becton Dickinson) offers 2.8%. MDT (Medtronic) provides a richer 3.7%, but STE's superior 20-year growth streak and lower payout ratio (vs. BDX's 106%) highlight its conservative profile. The sector average hovers around 1-1.7% for large caps, making STE an average-to-attractive option for balanced income in healthcare equipment.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to streamline your research today.

Is This Stock Attractive for Dividend Investors?

STERIS plc (STE) suits dividend growth investors prioritizing consistency over high current yields, given its 20-year streak of increases and 10% average growth rate. Long-term holders in healthcare may appreciate the defensive moat from essential sterilization services, which generate recurring revenue and support earnings coverage exceeding 2.8x. Conservative investors could value the low 33.5% payout ratio and robust FCF, minimizing cut risks even in downturns. However, those chasing yields above 2-3% might look elsewhere, as STE's 1.21% lags sectors like utilities. Income seekers benefit from quarterly payouts, but total returns historically blend modest dividends with stock appreciation from sector tailwinds like infection control demand. Balanced portfolios often include such names for stability without sacrificing growth potential.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations